Abstract
Multi-RNA co-transfection is starting to be employed to stimulate immune responses to SARS-CoV-2 viral infection. While there are good reasons to utilize such an approach, there is little background on whether there are synergistic RNA-dependent cellular effects. To address this issue, we use transcriptome-induced phenotype remodeling (TIPeR) via phototransfection to assess whether mRNAs encoding the Spike and Nucleocapsid proteins of SARS-CoV-2 virus into single human astrocytes (an endogenous human cell host for the virus) and mouse 3T3 cells (often used in high-throughput therapeutic screens) synergistically impact host cell biologies. An RNA concentration-dependent expression was observed where an increase of RNA by less than 2-fold results in reduced expression of each individual RNAs. Further, a dominant inhibitory effect of Nucleocapsid RNA upon Spike RNA translation was detected that is distinct from codon-mediated epistasis. Knowledge of the cellular consequences of multi-RNA transfection will aid in selecting RNA concentrations that will maximize antigen presentation on host cell surface with the goal of eliciting a robust immune response. Further, application of this single cell stoichiometrically tunable RNA functional genomics approach to the study of SARS-CoV-2 biology promises to provide details of the cellular sequalae that arise upon infection in anticipation of providing novel targets for inhibition of viral replication and propagation for therapeutic intervention.
Introduction
As the development of multi-antigen mRNA vaccines—such as bivalent boosters—accelerates, understanding the intracellular behavior of multiple mRNA species becomes paramount. Standard delivery methods like Lipid Nanoparticles (LNPs) operate on bulk cell populations, obscuring the precise stoichiometry of mRNA delivery at the single-cell level. This study addresses the phenomenon of RNA-dependent translation interference, where different viral mRNAs compete for the cell's translational machinery. By utilizing human astrocytes, a key host cell for SARS-CoV-2 in the central nervous system, researchers investigated how the ratio of Spike (S) to Nucleocapsid (N) mRNA influences protein output.
Methodology: Single-Cell Phototransfection
To overcome the limitations of bulk transfection, the authors employed Transcriptome-Induced Phenotype Remodeling (TIPeR) via phototransfection. This technique uses a high-precision femtosecond infrared laser to create transient, nanometer-sized pores in the cell membrane, allowing specific concentrations of mRNA to diffuse into the cytoplasm from the surrounding medium.
The experimental setup included:
- Single-Cell Titration: By varying the mRNA concentration in the extracellular medium, researchers could precisely control the amount of mRNA entering an individual cell.
- Microfluidic Gradient Device: A 7-inlet microfluidic chamber was used to create precise concentration gradients across a field of cells, enabling high-throughput, tunable functional genomics.
- Cellular Models: The study compared primary human astrocytes with mouse 3T3 and rat PC12 cells to evaluate species-specific translational efficiencies.
Results and Discussion
The "More is Less" Paradox
A striking finding was that protein expression does not scale linearly with mRNA concentration. Increasing the mRNA concentration by less than two-fold (from ~0.35 µg/mL to ~0.70 µg/mL) paradoxically resulted in reduced protein expression. This suggests a "sweet spot" for translation, beyond which the cellular machinery becomes saturated or triggers inhibitory interference.
Nucleocapsid-Mediated Translation Interference
When S and N mRNAs were co-transfected, a significant directional interference was observed. The Nucleocapsid mRNA acted as a dominant inhibitor, reducing Spike protein translation by approximately 50%. Conversely, the presence of Spike mRNA enhanced the translation of the Nucleocapsid protein by about 1.5-fold. This unidirectionality suggests that the interference is not merely a result of general competition for ribosomes (codon-mediated epistasis) but likely involves specific RNA-binding proteins (RBPs) recruited by the N-mRNA that selectively block Spike translation.
Species-Specific Sensitivity
Human astrocytes were found to be significantly less efficient at translating viral mRNA compared to common laboratory cell lines like mouse 3T3 cells. This finding underscores the importance of using primary human cell models for therapeutic screening, as results from standard cell lines may not accurately reflect human physiological responses.
Conclusion
This research demonstrates that for mRNA-based therapeutics, increasing the dose does not always yield higher protein output. Precise titration and an understanding of sequence-specific competition for translational resources are essential for optimizing antigen presentation and immune responses. The application of single-cell phototransfection provides a powerful tool for dissecting these complex viral dynamics and identifying novel therapeutic targets.
Summary updated